171 related articles for article (PubMed ID: 7040086)
1. Vancomycin plus gentamicin and cotrimoxazole for prevention of infections in neutropenic cancer patients (a comparative, placebo-controlled pilot study).
Malarme M; Meunier-Carpentier F; Klastersky J
Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1315-22. PubMed ID: 7040086
[No Abstract] [Full Text] [Related]
2. Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer.
Braine HG; Stuart RK; Saral R; Lietman PS
Rev Infect Dis; 1982; 4(2):586-92. PubMed ID: 7051248
[TBL] [Abstract][Full Text] [Related]
3. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
Bow EJ; Rayner E; Scott BA; Louie TJ
Antimicrob Agents Chemother; 1987 Apr; 31(4):551-7. PubMed ID: 3300532
[TBL] [Abstract][Full Text] [Related]
4. Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.
J Infect Dis; 1984 Sep; 150(3):372-9. PubMed ID: 6384377
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study.
Cruciani M; Concia E; Navarra A; Perversi L; Bonetti F; Aricò M; Nespoli L
Infection; 1989; 17(2):65-9. PubMed ID: 2654019
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic use of gentamicin, cotrimoxazole, and cephalosporins in 10 hospitals in Czechoslovakia.
Grunt J; Antal M; Krcméry V
Am J Hosp Pharm; 1986 Jan; 43(1):141-3. PubMed ID: 3485376
[No Abstract] [Full Text] [Related]
7. [Prophylactic controlled trials with cotrimoxazole in afebrile neutropenic patients with malignant hemopathies].
Scaglione C; Tormena AM; Pavlovsky S
Sangre (Barc); 1982; 27(5):912-8. PubMed ID: 6820192
[No Abstract] [Full Text] [Related]
8. [Co-trimoxazole chemoprophylaxis in immunocompromised patients: analysis of the literature].
Gava R; Carli M
G Clin Med; 1989 Jan; 70(1):37-9, 42-6. PubMed ID: 2668092
[No Abstract] [Full Text] [Related]
9. Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora.
Kauffman CA; Liepman MK; Bergman AG; Mioduszewski J
Am J Med; 1983 Apr; 74(4):599-607. PubMed ID: 6837588
[No Abstract] [Full Text] [Related]
10. Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients.
Henry SA
Am J Med; 1984 Apr; 76(4):645-51. PubMed ID: 6369979
[TBL] [Abstract][Full Text] [Related]
11. Norfloxacin for prevention of bacterial infections in granulocytopenic patients.
Winston DJ; Ho WG; Champlin RE; Karp J; Bartlett J; Finley RS; Joshi JH; Talbot G; Levitt L; Deresinski S
Am J Med; 1987 Jun; 82(6B):40-6. PubMed ID: 3037899
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial comparing trimethoprim/sulfamethoxazole and trimethoprim for infection prophylaxis in hospitalized granulocytopenic patients.
Bow EJ; Louie TJ; Riben PD; McNaughton RD; Harding GK; Ronald AR
Am J Med; 1984 Feb; 76(2):223-33. PubMed ID: 6364804
[TBL] [Abstract][Full Text] [Related]
13. Treatment of bacterial infections.
Thirumoorthi MC; Dajani AS
Semin Perinatol; 1985 Jan; 9(1):38-46. PubMed ID: 3881829
[No Abstract] [Full Text] [Related]
14. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
Granowetter L; Wells H; Lange BJ
Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic co-trimoxazole and lactobacilli preparation in neutropenic patients.
Ekert H; Jurk IH; Waters KD; Tiedemann K
Med Pediatr Oncol; 1980; 8(1):47-51. PubMed ID: 6969348
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomly controlled trial of three antibiotic combinations for empirical therapy of suspected sepsis in neutropenic cancer patients.
Gaya H; Klastersky J; Schimpff SC; Fière D; Widmaier S; Nagel G
Eur J Cancer (1965); 1975 Aug; 11suppl():5-8. PubMed ID: 767119
[No Abstract] [Full Text] [Related]
17. Prophylaxis in severe granulocytopenia.
Thompson EI; Callihan TR; Mauer AM
Adv Intern Med; 1984; 29():193-214. PubMed ID: 6369925
[No Abstract] [Full Text] [Related]
18. Outbreak of co-trimoxazole- and gentamicin-resistant Klebsiella aerogenes bacteremia in neutropenic patients receiving oral co-trimoxazole prophylaxis.
Leahy MF; Humble MW
Aust N Z J Med; 1983 Dec; 13(6):636-8. PubMed ID: 6372773
[TBL] [Abstract][Full Text] [Related]
19. Use of trimethoprim-sulfamethoxazole singly and in combination with other antibiotics in immunocompromised patients.
Young LS; Hindler J
Rev Infect Dis; 1987; 9 Suppl 2():S177-83. PubMed ID: 3554456
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future.
Zinner SH
Schweiz Med Wochenschr Suppl; 1983; 14():7-14. PubMed ID: 6361995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
